Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in… GlobalData Dec 11, 2024 Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
US FDA declines to approve two more China-tested drugs Reuters May 4, 2022 The decisions could add pressure on Chinese stocks, especially biotech companies, at a time shares of several US-listed Chinese…
Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug Reuters Jun 7, 2020 The experimental drug, JS016, is also expected to begin human study in the US in the second quarter of this year, through…
